These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3094)

  • 21. Propranolol vs metoprolol vs labetalol: a comparative study in essential hypertension.
    Kubik MM; Coote JH
    Eur J Clin Pharmacol; 1984; 26(1):1-6. PubMed ID: 6143666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penbutolol, a new non-selective beta-adrenergic blocking compound in the treatment of hypertension. A comparision with propranolol.
    Frick MH; Hartikainen M; Pörsti P
    Ann Clin Res; 1978 Apr; 10(2):105-6. PubMed ID: 28071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different antihypertensive effect of beta-blocking drugs in low and normal-high renin hypertension.
    Kralberg BE; Tolagen K
    Am J Med; 1976 May; 60(6):891-6. PubMed ID: 14504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of intravenous AH 5158 (ibidomide) and propranolol in asthma.
    Skinner C; Gaddie J; Palmer KN
    Br Med J; 1975 Apr; 2(5962):59-61. PubMed ID: 236806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative beta-adrenoreceptor-blocking effects and pharmacokinetics or propranolol and pindolol in hypertensive Africans.
    Salako LA; Falase AO; Aderounmu AF
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():393s-396s. PubMed ID: 232026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol.
    Franciosa JA; Freis ED; Conway J
    Circulation; 1973 Jul; 48(1):118-24. PubMed ID: 4150000
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of two adrenergic beta-receptor blocking agents, alprenolol and propranolol, in treatment of angina pectoris.
    Heterington DJ; Comerford MB; Nyberg G; Besterman EM
    Br Heart J; 1973 Mar; 35(3):320-33. PubMed ID: 4632566
    [No Abstract]   [Full Text] [Related]  

  • 28. Relationship between adrenergic blocking and antihypertensive effects of beta receptor antagonists.
    Rahn KH
    Adv Clin Pharmacol; 1976; 11():14-8. PubMed ID: 25567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
    Levy JV
    Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of 4 beta-adrenoceptor blocking drugs on blood pressure and exercise heart rate in hypertension.
    Harry JD; Knapp MF; Linden RJ; Stoker JB; Newcombe C
    Eur J Cardiol; 1979 Aug; 10(2):131-41. PubMed ID: 38965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertension, exercise, and beta-adrenergic blockade.
    Ades PA; Gunther PG; Meacham CP; Handy MA; LeWinter MM
    Ann Intern Med; 1988 Oct; 109(8):629-34. PubMed ID: 2901818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
    Bjerle P; Jacobsson KA; Agert G
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
    [No Abstract]   [Full Text] [Related]  

  • 33. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
    Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
    Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acebutolol in essential hypertension: results of two multicenter studies against placebo and propranolol.
    Davidov M
    Am Heart J; 1985 May; 109(5 Pt 2):1158-67. PubMed ID: 2859780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cardioselective and nonselective beta-blockade on dynamic exercise performance in mildly hypertensive men.
    Leenen FH; Coenen CH; Zonderland M; Maas AH
    Clin Pharmacol Ther; 1980 Jul; 28(1):12-21. PubMed ID: 6104554
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparative trial of fixed ratio beta-adrenoceptor blocker and diuretic combination products in moderate hypertension.
    Watt SJ; Lee MR
    Pharmatherapeutica; 1980; 2(7):487-93. PubMed ID: 6111083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-adrenoceptor-blocking agents in the management of hypertension.
    Prichard BN
    Cardiology; 1979; 64 Suppl 1():44-87. PubMed ID: 42488
    [No Abstract]   [Full Text] [Related]  

  • 39. The antihypertensive action of several beta-adrenoreceptor-blocking drugs.
    Waal-Manning HJ
    N Z Med J; 1976 Apr; 83(561):223-6. PubMed ID: 8748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
    Hansson L
    Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.